Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma

Published:2009-06 Issue:6 Volume:145 Page:681-708
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Lonial Sagar,Cavenagh Jamie

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07649.x/fullpdf

Reference181 articles.

1. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial;Abdelkefi;Blood,2008

2. Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide for the treatment of previously untreated multiple myeloma;Ailawadhi;Haematologica,2008

3. VAD-based regimens as primary treatment for multiple myeloma;Alexanian;American Journal of Hematology,1990

4. Primary dexamethasone treatment of multiple myeloma;Alexanian;Blood,1992

5. Clinically relevant end points and new drug approvals for myeloma;Anderson;Leukemia,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

2. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma;2023

3. Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma;American Journal of Clinical Oncology;2020-01-27

4. Cellular immunotherapy in multiple myeloma;The Korean Journal of Internal Medicine;2019-09-01

5. Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first-line induction therapy for newly diagnosed multiple myeloma in a single institution of China;Asia-Pacific Journal of Clinical Oncology;2016-10-14